search
Back to results

Best Start - Weight Management During Pregnancy

Primary Purpose

Obesity in Pregnancy

Status
Active
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Foodwise in Pregnancy
Sponsored by
Cwm Taf University Health Board (NHS)
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity in Pregnancy

Eligibility Criteria

16 Years - undefined (Child, Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Pregnant women who at their early pregnancy dating scan (optimum time 12 weeks gestation, but with a tolerance of up to 16 full weeks gestation for women who book late) have a BMI of 30 or over and reside in Cwm Taf University Health Board area.
  • Aged over 16.
  • Capable of giving informed consent.
  • Singleton and multiple pregnancies.

Exclusion Criteria:

  • Pregnant women who at their early pregnancy dating scan (optimum time 12 weeks gestation, but with a tolerance of up to 16 full weeks gestation for women who book late) have a BMI of less than 29.9 and reside in Cwm Taf University Health Board area.
  • Aged under 16.
  • Incapable of giving informed consent.
  • Any women who have pre-existing diabetes, or develop gestational diabetes during their pregnancy.
  • Any health condition that means the health professional looking after the patient feels would contra-indicate involvement in this programme (e.g. losing the ability to consent during the programme)

Sites / Locations

  • Royal Glamorgan Hospital
  • Prince Charles Hospital
  • Ysbyty Cwm Cynon Hospital
  • Ysbyty Cwm Rhondda Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Participants in the Intervention Group

Participants in the Control Group

Arm Description

Intervention Group - will undertake a programme of 7 x 2 hour group sessions, following the scripted 'Foodwise in Pregnancy' manual of nutrition information; practical cooking sessions; and information on low impact exercise.

Control Group - will continue with routine antenatal care, unchanged.

Outcomes

Primary Outcome Measures

Body Mass Index - Weight and height recordings will be used to calculate BMI in kg/m^2 at 12 weeks.
Body Mass Index.
Weight of participant recorded in kg at 36 weeks.
The odds ratio of pregnant women with a BMI of ≥30 who do not gain excessive weight and achieve the optimum recommended weight gain during pregnancy of 5-9.1kg in the intervention group compared with the control group.

Secondary Outcome Measures

Number of babies born Pre-term - babies born <37 weeks.
Babies born to participants of the study at <37 weeks gestation.
Number of participants identified with Pre-eclampsia - New hypertension presenting after 20 weeks of pregnancy with significant proteinuria.
Participants will be monitored for signs of pre-eclampsia - hypertension and proteinuria.
Number of participants identified with Thromboembolism - venous thromboembolism (VTE) - deep vein thrombosis(DVT) or pulmonary embolism (PE).
All participants will be monitored for VTE, DVT and PE in early pregnancy and again during the intrapartum and postpartum periods.
Mode of delivery - Caesarean section.
Participants delivering by Caesarean section will be recorded.
Post surgical site infection - a type of healthcare associated infection in which a wound infection occurs after an invasive (surgical) procedure.
Signs of post post-surgical infections will be monitored and treated.
Number of participants identified with Postpartum haemorrhage (PPH); Primary and Secondary.
Participants will be monitored for signs of PPH. PPH can be broken down into stages: Stage 1: 500-999ml blood loss; Stage 2: 1000-1499ml blood loss; Stage 3:>1500ml blood loss (major obstetric haemorrhage); Primary postpartum haemorrhage (PPH) the loss of > 500ml of blood after vaginal delivery or < 1000ml of blood after caesarean section delivery within 24 hours of delivery. Secondary PPH is defined as abnormal bleeding from the birth canal between 24 hours and 12 weeks postnatally.
Number of participants referred to the study.
Number of obese pregnant women referred into the programme by their midwife.
Number of participants Breastfeeding at birth, and exclusively breastfeeding at 10 days and 6 months.
The number of study participants who breastfeed at birth, and exclusively breastfeed at 10 days and 6 months.
Percentage of weight management programme sessions attended by participants.
Uptake and acceptability of the programme to obese pregnant women measured through the percentage of weight management programme sessions attended.
Number of post programme interviews/focus groups with eligible participants, following a scripted questionnaire.
Uptake and acceptability of the programme to obese pregnant women measured through the number of post study interviews/focus groups with eligible participants.
Self reported changes in study participants measured through a self completed questionnaire at the end of the weight management programme.
Self reported changes in nutrition knowledge, skills, physical activity levels, confidence and behaviour.
Number of low birth weight babies born, weighing < 2.5kg.
Weight of baby at birth lower than 2.5kg.
Number of high birth weight babies born - Macrosomia.
Weight of baby at birth higher than 3.99kg
Number of Stillbirths.
Stillbirth - Baby born dead after 24 weeks gestation.
Number of Neonatal deaths.
Neonatal death - Death of a baby within the first 28 days of life.
Number of babies born needing Transitional Care.
Babies born needing enhanced care but not Special Care Baby Unit (SCBU)admission.
Number of babies born needing Neonatal intensive care unit (NICU) admission.
Babies born needing intensive care intervention.
Rate of obesity in children born to study participants at age 4-5 years. Weight and height will be combined to calculate BMI in kg/m^2.
Rate of obesity measured at age 4-5 years, recorded as part of the Child Measurement Programme for Wales (All Wales Surveillance System).
Acceptability of the programme to relevant staff groups - measured through semi-structured audio recorded interview (face-to-face or via telephone).
The acceptability of the programme to relevant staff groups will be assessed though 1:1 or focus group sessions. A sample of healthcare professionals to include midwife, dietician, healthy lifestyle support worker, obstetrician, sonographer, anaesthetist. Open and closed ended questioning.

Full Information

First Posted
January 28, 2019
Last Updated
February 15, 2023
Sponsor
Cwm Taf University Health Board (NHS)
Collaborators
Burdett Trust for Nursing, Public Health Wales NHS Trust, Swansea University, Cardiff Metropolitan University, Cardiff University
search

1. Study Identification

Unique Protocol Identification Number
NCT03875300
Brief Title
Best Start - Weight Management During Pregnancy
Official Title
Best Start - Weight Management During Pregnancy
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
July 1, 2017 (Actual)
Primary Completion Date
September 7, 2018 (Actual)
Study Completion Date
May 1, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Cwm Taf University Health Board (NHS)
Collaborators
Burdett Trust for Nursing, Public Health Wales NHS Trust, Swansea University, Cardiff Metropolitan University, Cardiff University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The investigators know that being overweight during pregnancy increases the health risks to both mum and baby. There is good evidence that diet or exercise, or both, during pregnancy can reduce excessive weight gain. The Best Start study aims to test the theory that obese pregnant women with a Body Mass Index (BMI) of 30 or over who participate in a structured programme of nutrition and lifestyle advice (Foodwise in Pregnancy ™) will achieve the recommended weight gain during pregnancy of no less than 5kg and no more than 9.1kg. The investigators would like to find out if pregnant women with a BMI of 30 or over who receive the Best Start intervention are more likely to effectively manage weight gain during pregnancy. To achieve this, the investigators will undertake a trial that randomly puts participants into an experimental group, or a control group, which will compare those who receive the intervention to those who continue with routine antenatal care. The investigators are aiming to recruit around 500 women during the study period. 250 will receive the Best Start intervention, and 250 will continue with routine antenatal care. The investigators would also like to find out if women who gain the recommended weight during pregnancy have better outcomes, compared to women who gain more or less weight. To do this the investigators will look at the routine information collected during antenatal and postnatal care, for both mum and baby. To do this regardless of the group clients are randomised to, the investigators will ask for permission to look at the routine information within the participants maternity record. This information includes, weight gained during pregnancy, whether the baby is born early, the type of labour and delivery, and any complications during the pregnancy or delivery that may have resulted in the need for additional care for mum or baby. The results of the study will be prepared for publication in scientific journals, and for presentation at scientific conferences. All participants will be able to obtain a copy of the results once they have been published and any information that could identify participants will be removed.
Detailed Description
The intervention will invite obese pregnant women with a BMI ≥30 to participate in a research study where participants may be offered a programme of nutrition and lifestyle advice, unless participants meet the exclusion criteria. The programme of nutrition and lifestyle advice will comprise a series of weekly 7 x 2 hour group sessions, which will be delivered in community venues by trained Healthy Lifestyle Support Workers (HLSWs) employed within the maternity service. The group sessions will follow the scripted "Foodwise in PregnancyTM" manual of nutrition information; practical cooking sessions; and information on low impact exercise e.g. walking. 'Foodwise in PregnancyTM' has been developed by a group of NHS Dietitians and Midwives and is adapted from the existing Foodwise for Life programme. Pedometers will be provided at session three to raise participants awareness of the benefits of physical activity. The programme is participative in its approach to experiential learning. The group sessions will also promote breastfeeding (All Wales Maternity Strategy Key Performance Indicator/Measure) to assist healthy weight gain for babies, healthy weaning and the importance of play and physical activity. Delivery of the sessions will be quality assured by a specialist public health dietitian and public health midwife employed within Cwm Taf University Health Board. Because eligible women will initially be referred by a midwife, all midwives will be trained by a public health dietitian on the "Eating for 1, Healthy and Active for 2" Royal College of Midwives accredited compact training, to ensure a sensitive and effective conversation (using motivational interviewing techniques) that raises the issue of excess weight in pregnancy. The Healthy Lifestyle Support Workers, delivering the intervention, will also attend this training.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity in Pregnancy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomised Control Trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
526 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Participants in the Intervention Group
Arm Type
Experimental
Arm Description
Intervention Group - will undertake a programme of 7 x 2 hour group sessions, following the scripted 'Foodwise in Pregnancy' manual of nutrition information; practical cooking sessions; and information on low impact exercise.
Arm Title
Participants in the Control Group
Arm Type
No Intervention
Arm Description
Control Group - will continue with routine antenatal care, unchanged.
Intervention Type
Behavioral
Intervention Name(s)
Foodwise in Pregnancy
Intervention Description
A 7 week programme of nutrition and lifestyle advice, delivered in community venues by trained Healthy Lifestyle Support Workers (HLSWs). Participants must meet study inclusion criteria.
Primary Outcome Measure Information:
Title
Body Mass Index - Weight and height recordings will be used to calculate BMI in kg/m^2 at 12 weeks.
Description
Body Mass Index.
Time Frame
12 weeks gestation.
Title
Weight of participant recorded in kg at 36 weeks.
Description
The odds ratio of pregnant women with a BMI of ≥30 who do not gain excessive weight and achieve the optimum recommended weight gain during pregnancy of 5-9.1kg in the intervention group compared with the control group.
Time Frame
36 weeks gestation.
Secondary Outcome Measure Information:
Title
Number of babies born Pre-term - babies born <37 weeks.
Description
Babies born to participants of the study at <37 weeks gestation.
Time Frame
<37 weeks gestation
Title
Number of participants identified with Pre-eclampsia - New hypertension presenting after 20 weeks of pregnancy with significant proteinuria.
Description
Participants will be monitored for signs of pre-eclampsia - hypertension and proteinuria.
Time Frame
20 weeks +.
Title
Number of participants identified with Thromboembolism - venous thromboembolism (VTE) - deep vein thrombosis(DVT) or pulmonary embolism (PE).
Description
All participants will be monitored for VTE, DVT and PE in early pregnancy and again during the intrapartum and postpartum periods.
Time Frame
Participant booking appointment to 4 weeks postpartum.
Title
Mode of delivery - Caesarean section.
Description
Participants delivering by Caesarean section will be recorded.
Time Frame
Date of delivery.
Title
Post surgical site infection - a type of healthcare associated infection in which a wound infection occurs after an invasive (surgical) procedure.
Description
Signs of post post-surgical infections will be monitored and treated.
Time Frame
Date of delivery to 4 weeks postpartum.
Title
Number of participants identified with Postpartum haemorrhage (PPH); Primary and Secondary.
Description
Participants will be monitored for signs of PPH. PPH can be broken down into stages: Stage 1: 500-999ml blood loss; Stage 2: 1000-1499ml blood loss; Stage 3:>1500ml blood loss (major obstetric haemorrhage); Primary postpartum haemorrhage (PPH) the loss of > 500ml of blood after vaginal delivery or < 1000ml of blood after caesarean section delivery within 24 hours of delivery. Secondary PPH is defined as abnormal bleeding from the birth canal between 24 hours and 12 weeks postnatally.
Time Frame
24 hours post-delivery to 12 weeks postpartum.
Title
Number of participants referred to the study.
Description
Number of obese pregnant women referred into the programme by their midwife.
Time Frame
July 2017-September 2018.
Title
Number of participants Breastfeeding at birth, and exclusively breastfeeding at 10 days and 6 months.
Description
The number of study participants who breastfeed at birth, and exclusively breastfeed at 10 days and 6 months.
Time Frame
Postnatal; Birth; 10 days and 6 months.
Title
Percentage of weight management programme sessions attended by participants.
Description
Uptake and acceptability of the programme to obese pregnant women measured through the percentage of weight management programme sessions attended.
Time Frame
Programme completion, an average of 7 weeks.
Title
Number of post programme interviews/focus groups with eligible participants, following a scripted questionnaire.
Description
Uptake and acceptability of the programme to obese pregnant women measured through the number of post study interviews/focus groups with eligible participants.
Time Frame
Programme completion, an average of 7 weeks.
Title
Self reported changes in study participants measured through a self completed questionnaire at the end of the weight management programme.
Description
Self reported changes in nutrition knowledge, skills, physical activity levels, confidence and behaviour.
Time Frame
Programme completion, an average of 7 weeks.
Title
Number of low birth weight babies born, weighing < 2.5kg.
Description
Weight of baby at birth lower than 2.5kg.
Time Frame
At birth.
Title
Number of high birth weight babies born - Macrosomia.
Description
Weight of baby at birth higher than 3.99kg
Time Frame
At birth.
Title
Number of Stillbirths.
Description
Stillbirth - Baby born dead after 24 weeks gestation.
Time Frame
24 weeks gestation to date of delivery.
Title
Number of Neonatal deaths.
Description
Neonatal death - Death of a baby within the first 28 days of life.
Time Frame
Date of birth to 28 days.
Title
Number of babies born needing Transitional Care.
Description
Babies born needing enhanced care but not Special Care Baby Unit (SCBU)admission.
Time Frame
From birth to 14 days postpartum.
Title
Number of babies born needing Neonatal intensive care unit (NICU) admission.
Description
Babies born needing intensive care intervention.
Time Frame
From birth to 14 days postpartum.
Title
Rate of obesity in children born to study participants at age 4-5 years. Weight and height will be combined to calculate BMI in kg/m^2.
Description
Rate of obesity measured at age 4-5 years, recorded as part of the Child Measurement Programme for Wales (All Wales Surveillance System).
Time Frame
Age 4-5 years.
Title
Acceptability of the programme to relevant staff groups - measured through semi-structured audio recorded interview (face-to-face or via telephone).
Description
The acceptability of the programme to relevant staff groups will be assessed though 1:1 or focus group sessions. A sample of healthcare professionals to include midwife, dietician, healthy lifestyle support worker, obstetrician, sonographer, anaesthetist. Open and closed ended questioning.
Time Frame
Up to 12 months.
Other Pre-specified Outcome Measures:
Title
Smoking status of study participant. Self reported measure and confirmed using piCObaby Smokerlyzer CO parts per million (PPM).
Description
Self reported and CO validated measurement of study participant smoking status at initial booking interview and self-reported at 36 weeks.
Time Frame
Through study completion, an average of 1 year.
Title
Folic acid compliance of study participant. Self reported measure. Pre-conception folic acid and early pregnancy folic acid at initial booking assessment. Recorded by Midwife.
Description
Self reported assessment confirmed and recorded by Midwife.
Time Frame
Through study completion, an average of 1 year.
Title
Socio-economic status of study participant derived from Welsh Index of Multiple Deprivation (WIMD) using Postcode.
Description
Socio-economic status assessed from WIMD category.
Time Frame
Through study completion, an average of 1 year.
Title
Alcohol consumption status of study participant at initial booking assessment and end of pregnancy. Self reported units consumed per week.
Description
Alcohol consumption status. At booking and end of pregnancy. Recorded by Midwife.
Time Frame
Through study completion, an average of 1 year.
Title
Substance misuse status at booking interview. Self reported recorded by Midwife.
Description
Substance misuse status.
Time Frame
Through study completion, an average of 1 year.

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Pregnant women who at their early pregnancy dating scan (optimum time 12 weeks gestation, but with a tolerance of up to 16 full weeks gestation for women who book late) have a BMI of 30 or over and reside in Cwm Taf University Health Board area. Aged over 16. Capable of giving informed consent. Singleton and multiple pregnancies. Exclusion Criteria: Pregnant women who at their early pregnancy dating scan (optimum time 12 weeks gestation, but with a tolerance of up to 16 full weeks gestation for women who book late) have a BMI of less than 29.9 and reside in Cwm Taf University Health Board area. Aged under 16. Incapable of giving informed consent. Any women who have pre-existing diabetes, or develop gestational diabetes during their pregnancy. Any health condition that means the health professional looking after the patient feels would contra-indicate involvement in this programme (e.g. losing the ability to consent during the programme)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Angela Jones
Organizational Affiliation
Public Health Wales NHS Trust
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Angela Jones
Organizational Affiliation
Public Health Wales NHS Trust
Official's Role
Study Director
Facility Information:
Facility Name
Royal Glamorgan Hospital
City
Llantrisant
ZIP/Postal Code
CF72 8XR
Country
United Kingdom
Facility Name
Prince Charles Hospital
City
Merthyr Tydfil
ZIP/Postal Code
CF47 9DT
Country
United Kingdom
Facility Name
Ysbyty Cwm Cynon Hospital
City
Mountain Ash
ZIP/Postal Code
CF45 4BZ
Country
United Kingdom
Facility Name
Ysbyty Cwm Rhondda Hospital
City
Tonypandy
ZIP/Postal Code
CF40 2LX
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Study findings will be disseminated via The Burdett Trust for Nursing, Cwm Taf University Health Board, Public Health Wales NHS Trust, health boards and interested clinicians and submission of a paper to a scientific journal for peer-review e.g. the British Journal of Midwifery. The results of our study will be prepared for publication in scientific journals, and for presentation at scientific conferences. All participants will be able to obtain a copy of the results once they have been published, no patient identifiable information will be included.
IPD Sharing Time Frame
It is anticipated that the initial study findings will be available for dissemination by approximately January 2021. The final Statistical Analysis Plan (SAP) is still to be determined.
IPD Sharing Access Criteria
Access criteria is still to be determined.

Learn more about this trial

Best Start - Weight Management During Pregnancy

We'll reach out to this number within 24 hrs